These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9252496)

  • 1. Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO.
    Hovorka R; Eckland DJ; Halliday D; Lettis S; Robinson CE; Bannister P; Young MA; Bye A
    Am J Physiol; 1997 Jul; 273(1 Pt 1):E192-201. PubMed ID: 9252496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test.
    Hovorka R; Bannister P; Eckland DJ; Halliday D; Murley DN; Rees SE; Young MA
    Diabet Med; 1998 Mar; 15(3):234-46. PubMed ID: 9545125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM.
    Glauber H; Wallace P; Brechtel G
    Diabetes; 1987 Oct; 36(10):1187-94. PubMed ID: 3308588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.
    Ader M; Ni TC; Bergman RN
    J Clin Invest; 1997 Mar; 99(6):1187-99. PubMed ID: 9077526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic glucose output in humans measured with labeled glucose to reduce negative errors.
    Levy JC; Brown G; Matthews DR; Turner RC
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E531-40. PubMed ID: 2679129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a variable tracer infusion method to determine glucose turnover in humans.
    Molina JM; Baron AD; Edelman SV; Brechtel G; Wallace P; Olefsky JM
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E16-23. PubMed ID: 2405697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated hepatic glucose production in children with cystic fibrosis.
    Kien CL; Horswill CA; Zipf WB; McCoy KS; O'Dorisio T
    Pediatr Res; 1995 May; 37(5):600-5. PubMed ID: 7603777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired modulation of hepatic glucose output overnight after a 72-h fast in normal man.
    Clore JN; Helm ST; Nestler JE; Blackard WG
    J Clin Endocrinol Metab; 1990 Apr; 70(4):865-8. PubMed ID: 2180979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic glycogen in humans. I. Direct formation after oral and intravenous glucose or after a 24-h fast.
    Radziuk J
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E145-57. PubMed ID: 2669511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat.
    McArthur MD; You D; Klapstein K; Finegood DT
    Am J Physiol; 1999 Apr; 276(4):E739-46. PubMed ID: 10198311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
    Trägårdh M; Møller N; Sørensen M
    J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early glycogenolysis and late glycogenesis in human liver after intravenous administration of galactose.
    Fried R; Beckmann N; Keller U; Ninnis R; Stalder G; Seelig J
    Am J Physiol; 1996 Jan; 270(1 Pt 1):G14-9. PubMed ID: 8772496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.
    Prager R; Wallace P; Olefsky JM
    J Clin Invest; 1986 Aug; 78(2):472-81. PubMed ID: 3525609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production.
    Ader M; Bergman RN
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E1020-32. PubMed ID: 2193527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes.
    Livesey G; Wilson PD; Dainty JR; Brown JC; Faulks RM; Roe MA; Newman TA; Eagles J; Mellon FA; Greenwood RH
    Am J Physiol; 1998 Oct; 275(4):E717-28. PubMed ID: 9755093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic glycogen in humans. II. Gluconeogenetic formation after oral and intravenous glucose.
    Radziuk J
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E158-69. PubMed ID: 2669512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
    Rebrin K; Steil GM; Mittelman SD; Bergman RN
    J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amino acid infusion on glucose production in trauma patients.
    Long CL; Nelson KM; Geiger JW; Theus WL; Clark JA; Laws HL; Blakemore WS
    J Trauma; 1996 Mar; 40(3):335-41. PubMed ID: 8601845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of triple- and dual-tracer techniques to estimate glucose appearance.
    Haidar A; Elleri D; Allen JM; Harris J; Kumareswaran K; Nodale M; Acerini CL; Wilinska ME; Jackson N; Umpleby AM; Evans ML; Dunger DB; Hovorka R
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1493-501. PubMed ID: 22454288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.